Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Chemical Society

• Publication date

  2003-01-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA0209363PMID 12526674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

  2000cited by this paper
• Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.

  2000cited by this paper
• Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidising free radicals under anaerobic conditions.

  2000cited by this paper
• Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome.

  1999cited by this paper
• Hypoxic regions exist in human prostate carcinoma.

  1999cited by this paper
• Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions.

  1999cited by this paper
• Direct evidence for bimodal DNA damage induced by tirapazamine.

  1998cited by this paper
• 1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity.

  1998cited by this paper
• Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study.

  1998cited by this paper
• Enzymology of tirapazamine metabolism: a review.

  1998cited by this paper
• Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.

  1997cited by this paper
• Dual action of tirapazamine in the induction of DNA strand breaks.

  1996cited by this paper
• Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).

  1995cited by this paper
• Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.

  1994cited by this paper
• A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.

  1993cited by this paper
• SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

  1993cited by this paper
• The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.

  1992cited by this paper
• Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.

  1991cited by this paper
• Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.

  1990cited by this paper
• Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity.

  1988cited by this paper
• Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233).

  1988cited by this paper
• Pulse radiolytic study of the interaction of SO4.- with deoxynucleosides. Possible implications for direct energy deposition.

  1987cited by this paper

• Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs

  2025cites this paper
• Catalyst-free synthesis of 1,2,3-triazole-N-oxide derivatives using tert-butyl nitrite: a novel strategy and synthetic applications

  2025cites this paper
• Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials

  2023cites this paper
• Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides

  2022cites this paper
• Ring-Selective Fragmentation in the Tirapazamine Molecule upon Low-Energy Electron Attachment

  2021influential citation
• Reaktionen in Tirapazamin induziert durch die Anlagerung von niederenergetischen Elektronen: Dissoziation versus Roaming von OH

  2020cites this paper
• Electroreduction of Derivatives of N,N'-Dioxides of Phenazine and Quinoxaline in Nonaqueous Media and in the Presence of Proton Donors of Medium Strength

  2020cites this paper
• Synthesis of quinone-based heterocycles of broad-spectrum anticancer activity

  2020cites this paper
• Reactions in Tirapazamine Induced by the Attachment of Low‐Energy Electrons: Dissociation Versus Roaming of OH

  2020cites this paper
• Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity

  2020cites this paper
• Development and Validation of a Kilogram-Scale Synthesis of Tirapazamine

  2020cites this paper
• Enzyme-Activated Generation of Reactive Oxygen Species from Heterocyclic N-Oxides under Aerobic and Anaerobic Conditions and Its Relevance to Hypoxia-Selective Prodrugs.

  2019cites this paper
• Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia

  2019cites this paper
• Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs.

  2019cites this paper
• Recent Advances in Glucose-Oxidase-Based Nanocomposites for Tumor Therapy.

  2019cites this paper
• Solvent-controlled chemoselective N-dealkylation-N-nitrosation or C-nitration of N-alkyl anilines with tert-butyl nitrite

  2019cites this paper
• Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses

  2019cites this paper
• Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors

  2019cites this paper
• Cytotoxicity of Tirapazamine (3-Amino-1,2,4-benzotriazine-1,4-dioxide)-Induced DNA Damage in Chicken DT40 Cells.

  2017cites this paper
• Anaerobe-Inspired Anticancer Nanovesicles.

  2017cites this paper
• An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.

  2017cites this paper
• Discovery of the hypoxia-activated prodrug SN30000

  2017cites this paper
• Antagonism in effectiveness of evofosfamide and doxorubicin through intermolecular electron transfer

  2017cites this paper
• Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions

  2016influential citation
• Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

  2015cites this paper
• Synthesis and anticancer activity evaluation of η(5)-C5(CH3)4R ruthenium complexes bearing chelating diphosphine ligands.

  2015cites this paper
• Drug Targets for Cancer Treatment: An Overview

  2015cites this paper
• Anticancer Drugs Acting via Radical Species: Radiotherapy and Photodynamic Therapy of Cancer

  2015cites this paper
• 7.06 – Tumor Radiation Biology

  2014cites this paper
• Hypoxia-directed drug strategies to target the tumor microenvironment.

  2014cites this paper
• Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5.

  2014cites this paper
• The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs.

  2014cites this paper
• Fragmentation of the quinoxaline N-oxide bond to the ˙OH radical upon one-electron bioreduction.

  2014cites this paper
• Toward Hypoxia-Selective DNA-Alkylating Agents Built by Grafting Nitrogen Mustards onto the Bioreductively Activated, Hypoxia-Selective DNA-Oxidizing Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine)

  2014cites this paper
• Prodrug Strategies for Targeting Tumour Hypoxia

  2014cites this paper
• Characterisation of radicals formed by the triazine 1,4-dioxide hypoxia-activated prodrug, SN30000.

  2014cites this paper
• Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide.

  2014cites this paper
• A spatially resolved pharmacokinetic/pharmacodynamic model for bystander effects of the hypoxia-activated prodrug PR-104A

  2013cites this paper
• Non‐DSB clusters : A. Tandem

  2013cites this paper
• Extra-hepatic isozymes from the CYP1 and CYP2 families as potential chemotherapeutic targets.

  2013cites this paper
• A mitochondria-targeted macrocyclic Mn(II) superoxide dismutase mimetic.

  2012cites this paper
• Targeting the metabolic microenvironment of tumors.

  2012cites this paper
• DNA strand cleavage by the phenazine di-N-oxide natural product myxin under both aerobic and anaerobic conditions.

  2012cites this paper
• Role of Phase I Metabolism in Drug Activation and Clinical Treatment Outcomes

  2012cites this paper
• On the reaction mechanism of tirapazamine reduction chemistry: unimolecular N-OH homolysis, stepwise dehydration, or triazene ring-opening.

  2012cites this paper
• Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs.

  2012cites this paper
• Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.

  2012cites this paper
• Electron and spin-density analysis of tirapazamine reduction chemistry.

  2012cites this paper
• Enzyme‐Activated Prodrug Strategies for Site‐Selective Drug Delivery

  2011cites this paper
• Bioactivation II: Phase I (Non-P450)

  2011cites this paper
• 5,6-Dimethyl-1,2,4-triazin-3-amine

  2011cites this paper
• Hypoxia Suppresses DNA Repair: Implications for Cancer Progression and Treatment

  2011cites this paper
• Prodrugs—from Serendipity to Rational Design

  2011cites this paper
• Synthetic DNA-Targeted Chemotherapeutic Agents And Related Tumor-Activated Prodrugs

  2010cites this paper
• DNA strand cleaving properties and hypoxia-selective cytotoxicity of 7-chloro-2-thienylcarbonyl-3-trifluoromethylquinoxaline 1,4-dioxide.

  2010cites this paper
• Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.

  2010cites this paper
• Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).

  2010cites this paper
• Synthesis, Crystal Structure, and Rotational Energy Profile of 3-Cyclopropyl-1,2,4-benzotriazine 1,4-Di-N-oxide

  2010cites this paper
• Release of nitrite from the antitubercular nitroimidazole drug PA-824 and analogues upon one-electron reduction in protic, non-aqueous solvent.

  2010cites this paper
• Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.

  2010cites this paper
• Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.

  2010cites this paper
• The remarkable yin and yang of tumour hypoxia

  2010influential citation
• Spin trapping of radicals other than the *OH radical upon reduction of the anticancer agent tirapazamine by cytochrome P450 reductase.

  2009cites this paper
• Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.

  2009cites this paper
• Tumor hypoxia as a modifier of DNA strand break and cross-link repair.

  2009cites this paper
• The importance of radiation chemistry to radiation and free radical biology (The 2008 Silvanus Thompson Memorial Lecture).

  2009cites this paper
• Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide.

  2009cites this paper
• Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.

  2009cites this paper
• Development of novel benzotriazines for drug discovery

  2009cites this paper
• One-electron reduction potential of the neutral guanyl radical in the GC base pair of duplex DNA.

  2009cites this paper
• Radiation chemistry comes before radiation biology

  2009cites this paper
• Design of anticancer prodrugs for reductive activation

  2009cites this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2009cites this paper
• Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells.

  2008cites this paper
• Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

  2008cites this paper
• Chemical modifications of AFM tips for the study of molecular recognition events.

  2008cites this paper
• Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.

  2008cites this paper
• Pulse radiolysis investigation on the mechanism of the catalytic action of Mn(II)-pentaazamacrocycle compounds as superoxide dismutase mimetics.

  2008cites this paper
• Chapter 6.3 Triazines, tetrazines and fused ring polyaza systems

  2008cites this paper
• Electronic structures and spin topologies of gamma-picoliniumyl radicals. A study of the homolysis of N-methyl-gamma-picolinium and of benzo-, dibenzo-, and naphthoannulated analogs.

  2008cites this paper
• Anticancer Drugs Acting via Radical Species, Photosensitizers and Photodynamic Therapy of Cancer

  2008cites this paper
• Theoretical study of molecular interaction between tirapazamine enzymatic catalysis metabolites and water

  2007cites this paper
• Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1,2,4-benzotriazine 1,4-dioxides with antitumor activity: the role of extravascular transport.

  2007cites this paper
• Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments.

  2007cites this paper
• Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.

  2007cites this paper
• Targeting tumors with hypoxia-activated cytotoxins.

  2007cites this paper
• On the mechanism of reaction of radicals with tirapazamine.

  2007cites this paper
• DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2).

  2007cites this paper
• Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards

  2007cites this paper
• Two‐step syntheses of 3‐methyl and 3‐phenyl‐1,2,4‐benzotriazines

  2006cites this paper
• THEORETICAL STUDY OF THE HYDROLYSIS MECHANISM OF METABOLIC PRODUCT FROM TIRAPAZAMINE'S UNDERGOING ENZYMATIC CATALYSIS

  2006cites this paper
• Alkyl radical adducts of aromatic N-oxides as hydrogen-abstracting agents: The reactivity of phenazine-N,N′-dioxide-methyl radical adduct

  2006cites this paper
• Combinations of Hypoxia-Targeting Compounds and Radiation-Activated Prodrugs with Ionizing Radiation

  2006cites this paper
• Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.

  2006cites this paper
• Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs.

  2006cites this paper
• Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

  2006cites this paper
• Sensor/effector drug design with potential relevance to cancer.

  2006cites this paper
• Complete 1H, 13C and 15N NMR assignment of tirapazamine and related 1,2,4‐benzotriazine N‐oxides

  2006cites this paper
• Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.

  2005cites this paper
• Time-resolved spectroscopy of the excited singlet states of tirapazamine and desoxytirapazamine.

  2005cites this paper